Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
Here are six things to know.
1. The United States helps fund AIDS treatment and research internationally through various initiatives. One of these initiatives is the President’s Emergency Plan for AIDS Relief. Additionally, the Global Fund partnership provides nearly $4 billion annually to combat AIDS, tuberculosis and malaria.
2. In total, the United States pays $6 billion each year for programs that purchase antiretroviral drugs for more than 11 million people worldwide with HIV, which causes AIDS, according to the report.
3. However, President Donald Trump’s administration has proposed at least $1.1 billion in cuts to global AIDS treatment programs, Jen Kates, a vice president at the Kaiser Family Foundation, told NYT.
4. Regardless of whether funding cuts were approved, people who currently receive drug treatments through the programs would maintain them, Hari Sastry, director of the State Department’s Office of U.S. Foreign Assistance Resources, told reporters, reports NYT. No further details were provided as far as how these patients would stay on treatment if the funding cuts gain approval, the report states.
5. Mr. Sastry also told reporters this week the White House planned to make sure America was “focusing our efforts in the 12 high-burden countries to achieve epidemic control,” reports NYT. Pepfar currently provides financial support to combat AIDS in more than 60 countries, many of which are in Africa.
6. Based on an amfAR calculation cited by the NYT, the proposed cuts to global AIDS programs could result in more than one million lives lost and more than 300,000 children becoming orphans.
Read the full report here.
More articles on healthcare quality:
Major teaching hospitals have lower mortality rates, study finds
Antibiotics ineffective for nearly 25% of pneumonia patients
CDC: Parasitic outbreaks linked to swimming pools have doubled since 2014
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
